Mycobacterium avium complex peritonitis in a pediatric patient on peritoneal dialysis: A case report

Shunsuke Yokota1, Kentaro Nishi1, Sho Ishiwa1,2

  • 1Division of Nephrology and Rheumatology.

Medicine
|June 15, 2021
PubMed
Abstract

Insights

Mycobacterium avium complex (MAC) peritonitis in patients on peritoneal dialysis (PD) is rare. This case report details a successful kidney transplant (KT) after a 1-year treatment regimen for MAC peritonitis, demonstrating a viable therapeutic approach.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Pediatric Medicine

Background:

  • Peritonitis caused by Mycobacterium avium complex (MAC) is a rare but serious complication in patients undergoing peritoneal dialysis (PD).
  • Optimal treatment strategies, including duration and timing for kidney transplantation (KT), remain undefined for MAC peritonitis in PD patients.

Observation:

  • A 4-year-old boy on PD for end-stage kidney disease developed MAC peritonitis following accidental PD catheter contamination.
  • Initial antibiotic treatment was successful, but peritonitis recurred, leading to diagnosis of MAC peritonitis via positive PD culture.

Findings:

  • The patient underwent a 1-year course of multi-drug anti-mycobacterial therapy (clarithromycin, ethambutol, rifampicin) with PD catheter removal and transition to hemodialysis.
  • Following treatment completion and an 8-month observation period without recurrence, the patient successfully received a living-donor kidney transplant.

Implications:

  • This case presents the first successful KT in a patient treated for MAC peritonitis, suggesting a potential treatment pathway.
  • A 1-year anti-mycobacterial therapy, catheter removal, and extended post-treatment observation may facilitate successful KT in MAC peritonitis patients, warranting further investigation.

Related Concept Videos